Advocacy and Outreach Committee

Advocacy and Outreach Committee

Description

Under the direction of the Board of Trustees, the Advocacy and Outreach Committee (AOC) develops and implements activities that influence research policy and funding decisions globally; increases members’ interest and ability to educate the public and policymakers about the importance of vision research; increases public awareness of ARVO and vision research; and establishes ARVO as a trusted source of information. In addition, the AOC assists ARVO in responding to scientific content of policy discussions relating to research guidelines worldwide.

Activities

  • The Committee (either as a whole or by sub-committee) sponsors workshops at the Annual Meeting. 
  • The Committee as a whole reports to the Board of Trustees at its regular meetings. 
  • Works with ARVO staff to keep members informed about issues related to science funding and policy worldwide that affect them.
  • Works with ARVO staff to develop testimony and responses to issues in science and vision-research related policy areas and science funding, where advice of experts is requested from legislative or regulatory offices in the U.S. and other countries.
  • With staff, develops initiatives and activities to support members’ capacity to educate and inform external audiences and advocate on behalf of vision research. 
    Assists and advises staff on U.S. and international media/press activities related to science/vision research-related stories and issues.

Composition

The Advocacy and Outreach Committee (AOC) consists of a mix of MDs and PhDs. The AOC should also have strong international representation. The AOC should include at least two Members-in-Training. 

Meetings

The Committee as a whole meets during the ARVO Annual Meeting and conducts business via ARVOConnect and e-mail and if needed by conference call during the year. Sub-committees meet at least once during the year via conference call or more as projects dictate. 

Roster

Chair

Peter Koulen, PhD, FARVO

Section: Retinal Cell Biology
University of Missouri-Kansas City
Kansas City , Mo.
Term: 05/03/2018 - 05/07/2020

Member

Matilda F. Chan, MD, PhD

Section: Cornea
University of California-San Francisco
San Francisco , Calif.
Term: 05/05/2016 - 05/02/2019

Member

Margaret DeAngelis, PhD

Section: Biochemistry and Molecular Biology
University of Utah
Salt Lake City , Utah
Term: 05/11/2017 - 05/07/2020

Member

Hosam Ibrahim-Elzembely, MD

Section: Cornea
Minia University
Minia , Egypt
Term: 05/05/2016 - 05/02/2019

Member

Catherine Jan, OD

Section: Visual Neuroscience
Beijing Tongren Eye Centre
Beijing , China
Term: 05/11/2017 - 05/07/2020

Member

Yaping Jin, MD, PhD

Section: Clinical and Epidemiologic Research
University of Toronto
Toronto , Ontario, Canada
Term: 05/05/2016 - 05/02/2019

Member

Breandan N. Kennedy, PhD

Section: Biochemistry and Molecular Biology
University College Dublin
Dubin, Ireland
Term: 05/05/2016 - 05/02/2019

Member

Teresa Puthussery, PhD

Section: Visual Neuroscience
University of California, Berkeley
Berkeley , Calif.
Term: 05/05/2016 - 05/02/2019

Member

Nicole Putnam, PhD

Section: Visual Psychophysics and Physiological Optics
Midwestern University
Phoenix , Ariz.
Term: 05/03/2018 - 05/06/2021

Member

Daisy Shu, BOptom (Hons), BSc.

Section: Lens
University of Sydney
Sydney , Australia
Term: 05/03/2018 - 05/06/2021

Member

Edmund Tsui, MD

Section: Immunology & Microbiology
New York University School of Medicine
New York , N.Y.
Term: 05/03/2018 - 05/06/2021

Member

Stephanie Watson, MBBS, FRANZCO, PhD

Section: Cornea
Save Sight Institute, University of Sydney
Sydney , Australia
Term: 05/11/2017 - 05/07/2020

Trustee Liaison

Raymond A. Applegate, OD, PhD, FARVO

Section: Visual Psychophysics and Physiological Optics
University of Houston
Houston , Texas
Term: 05/08/2014 - 05/02/2019

Ex Officio

Steven J. Fliesler, PhD, FARVO

Section: Retinal Cell Biology
SUNY-Buffalo / VA Medical Center - Buffalo
Buffalo , N.Y.
Term: 05/11/2017 - 05/07/2020

Ex Officio

W. Daniel Stamer, PhD, FARVO

Section: Physiology and Pharmacology
Duke University
Durham , N.C.
Term: 05/03/2018 - 05/07/2020

Ex Officio

Claude F. Burgoyne, MD, FARVO

Section: Glaucoma
Devers Eye Institute
Portland , Ore.
Term: 05/05/2016 - 05/02/2019

Ex Officio

Justine R. Smith, FRANZCO, PhD, FARVO

Section: Immunology and Microbiology
Flinders University
Adelaide , South Austrailia
Term: 05/11/2017 - 05/05/2022

Ex Officio

Iris M. Rush, CAE

ARVO
Executive Director

Staff Committee Liaison

Matt Windsor, PhD

ARVO
Senior Manager, Science Communication